Fernando Moura

Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a Heavily Pretreated TMB-H Metastatic Squamous Cell Lung Cancer with CDKN2A Mutation, PIK3CA Amplification and TPS 80%: A Case Report

Pedro Luiz Serrano Uson Junior, G. Botrus, Akemi Osawa, 2023, International journal of molecular sciences.

Real-World Prevalence of PD-L1 Expression Among Tumor Samples From Patients With Non-Small-Cell Lung Cancer.

C. Barrios, F. Zaffaroni, G. Werutsky, 2020, Clinical lung cancer.

Brazilian guidelines for the management of immune-related adverse events associated with checkpoint inhibitors

A. Buzaid, C. Ferreira, R. Munhoz, 2017 .

Predictive Value of Serum Carbohydrate Antigen 19-9 (CA19-9) for Early Mortality in Advanced Pancreatic Cancer

Pedro Luiz Serrano Uson Junior, F. Maluf, D. Bugano, 2018, Journal of Gastrointestinal Cancer.

Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis

S. E. Araújo, Pedro Luiz Serrano Uson Junior, G. Botrus, 2022, Scientific Reports.

Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma

P. Hoff, M. Braghiroli, J. Sabbaga, 2021, Clinics.

Clinical Course, Genetic, and Immunohistochemical Characterization of Solid Pseudopapillary Tumor of the Pancreas (Frantz Tumors) in a Brazilian Cohort

G. Schvartsman, A. Goldenberg, Pedro Luiz Serrano Uson Junior, 2022, Genes.

EGFR-RAD51 fusion in lung adenocarcinoma with systemic and intracranial response to osimertinib: A case report and review of the literature.

G. Schvartsman, Fernando Moura, Rubens Copia Sperandio, 2022, Lung cancer.

Worst outcomes according to RAS mutation variants: an analysis in patients with metastatic colorectal adenocarcinoma.

R. S. Carvalho, F. Maluf, D. Bugano, 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.